1-14 of 14
Bin Fang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer

Aslamuzzaman Kazi, Liwei Chen, Shengyan Xiang, Rajanikanth Vangipurapu, Hua Yang, Francisca Beato, Bin Fang, Terence M. Williams, Kazim Husain, Patrick Underwood, Jason B. Fleming, Mokenge Malafa, Eric A. Welsh, John Koomen, José Trevino, Saïd M. Sebti
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (14): 4012–4024.
https://doi.org/10.1158/1078-0432.CCR-20-4781
Published: 15 July 2021
View article titled, Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer
Open the PDF for Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Cell Type–specific Adaptive Signaling Responses to KRASG12C Inhibition

Hitendra S. Solanki, Eric A. Welsh, Bin Fang, Victoria Izumi, Lancia Darville, Brandon Stone, Ryan Franzese, Sandip Chavan, Fumi Kinose, Denis Imbody, John M. Koomen, Uwe Rix, Eric B. Haura
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (9): 2533–2548.
https://doi.org/10.1158/1078-0432.CCR-20-3872
Published: 01 May 2021
View article titled, Cell Type–specific Adaptive Signaling Responses to KRAS<sup>G12C</sup> Inhibition
Open the PDF for Cell Type–specific Adaptive Signaling Responses to KRAS<sup>G12C</sup> Inhibition in another window
Includes: Supplementary data
Journal Articles

Proteomic Analysis of CSF from Patients with Leptomeningeal Melanoma Metastases Identifies Signatures Associated with Disease Progression and Therapeutic Resistance

Inna Smalley, Vincent Law, Clayton Wyatt, Brittany Evernden, Bin Fang, John M. Koomen, Eric A. Welsh, Robert J.B. Macaulay, Peter A. Forsyth, Keiran S.M. Smalley
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (9): 2163–2175.
https://doi.org/10.1158/1078-0432.CCR-19-2840
Published: 01 May 2020
View article titled, Proteomic Analysis of CSF from Patients with Leptomeningeal Melanoma Metastases Identifies Signatures Associated with Disease Progression and Therapeutic Resistance
Open the PDF for Proteomic Analysis of CSF from Patients with Leptomeningeal Melanoma Metastases Identifies Signatures Associated with Disease Progression and Therapeutic Resistance in another window
Includes: Supplementary data
Journal Articles

HDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma

Fernanda Faião-Flores, Michael F. Emmons, Michael A. Durante, Fumi Kinose, Biswarup Saha, Bin Fang, John M. Koomen, Srikumar P. Chellappan, Silvya Stuchi Maria-Engler, Uwe Rix, Jonathan D. Licht, J. William Harbour, Keiran S.M. Smalley
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (18): 5686–5701.
https://doi.org/10.1158/1078-0432.CCR-18-3382
Published: 13 September 2019
View article titled, HDAC Inhibition Enhances the <em>In Vivo</em> Efficacy of MEK Inhibitor Therapy in Uveal Melanoma
Open the PDF for HDAC Inhibition Enhances the <em>In Vivo</em> Efficacy of MEK Inhibitor Therapy in Uveal Melanoma in another window
Includes: Supplementary data
Journal Articles

Combined BRAF and HSP90 Inhibition in Patients with Unresectable BRAFV600E-Mutant Melanoma

Zeynep Eroglu, Y. Ann Chen, Geoffrey T. Gibney, Jeffrey S. Weber, Ragini R. Kudchadkar, Nikhil I. Khushalani, Joseph Markowitz, Andrew S. Brohl, Leticia F. Tetteh, Howida Ramadan, Gina Arnone, Jiannong Li, Xiuhua Zhao, Ritin Sharma, Lancia N.F. Darville, Bin Fang, Inna Smalley, Jane L. Messina, John M. Koomen, Vernon K. Sondak, Keiran S.M. Smalley
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (22): 5516–5524.
https://doi.org/10.1158/1078-0432.CCR-18-0565
Published: 15 November 2018
View article titled, Combined BRAF and HSP90 Inhibition in Patients with Unresectable <em>BRAF</em><sup>V600E</sup>-Mutant Melanoma
Open the PDF for Combined BRAF and HSP90 Inhibition in Patients with Unresectable <em>BRAF</em><sup>V600E</sup>-Mutant Melanoma in another window
Includes: Supplementary data
Journal Articles

Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry–Based Phosphotyrosine Proteomics

Scott M. Haake, Jiannong Li, Yun Bai, Fumi Kinose, Bin Fang, Eric A. Welsh, Roy Zent, Jasreman Dhillon, Julio M. Pow-Sang, Y. Ann Chen, John M. Koomen, W. Kimryn Rathmell, Mayer Fishman, Eric B. Haura
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (22): 5605–5616.
https://doi.org/10.1158/1078-0432.CCR-15-1673
Published: 14 November 2016
View article titled, Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry–Based Phosphotyrosine Proteomics
Open the PDF for Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry–Based Phosphotyrosine Proteomics in another window
Includes: Supplementary data
Journal Articles

Abstract IA04: Using comprehensive proteomic approaches to map signaling adaptations to BRAF and BRAF/MEK inhibition

Inna V. Fedorenko, Kim H.T. Paraiso, Bin Fang, John M. Koomen, Keiran S.M. Smalley
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (4_Supplement): IA04.
https://doi.org/10.1158/1557-3265.PMS14-IA04
Published: 13 February 2015
View article titled, Abstract IA04: Using comprehensive proteomic approaches to map signaling adaptations to BRAF and BRAF/MEK inhibition
Journal Articles

Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non–Small Cell Lung Cancer

Takeshi Yoshida, Guolin Zhang, Matthew A. Smith, Alex S. Lopez, Yun Bai, Jiannong Li, Bin Fang, John Koomen, Bhupendra Rawal, Kate J. Fisher, Ann Y. Chen, Michiko Kitano, Yume Morita, Haruka Yamaguchi, Kiyoko Shibata, Takafumi Okabe, Isamu Okamoto, Kazuhiko Nakagawa, Eric B. Haura
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (15): 4059–4074.
https://doi.org/10.1158/1078-0432.CCR-13-1559
Published: 31 July 2014
View article titled, Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non–Small Cell Lung Cancer
Open the PDF for Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

Aaron P. Rapoport, Nicole A. Aqui, Edward A. Stadtmauer, Dan T. Vogl, Yin Yan Xu, Michael Kalos, Ling Cai, Hong-Bin Fang, Brendan M. Weiss, Ashraf Badros, Saul Yanovich, Gorgun Akpek, Patricia Tsao, Alan Cross, Dean Mann, Sunita Philip, Naseem Kerr, Andrea Brennan, Zhaohui Zheng, Kathleen Ruehle, Todd Milliron, Scott E. Strome, Andres M. Salazar, Bruce L. Levine, Carl H. June
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (5): 1355–1365.
https://doi.org/10.1158/1078-0432.CCR-13-2817
Published: 02 March 2014
View article titled, Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells
Open the PDF for Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells in another window
Includes: Supplementary data
Journal Articles

Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia

Ivana Gojo, Ming Tan, Hong-Bin Fang, Mariola Sadowska, Rena Lapidus, Maria R. Baer, France Carrier, Jan H. Beumer, Bean N. Anyang, Rakesh K. Srivastava, Igor Espinoza-Delgado, Douglas D. Ross
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (7): 1838–1851.
https://doi.org/10.1158/1078-0432.CCR-12-3165
Published: 02 April 2013
View article titled, Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia
Open the PDF for Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

Abstract IA2: Network models in oncogene-addicted lung cancer

Eric B. Haura, Takeshi Yoshida, Bin Fang, Alexey Stukalov, Steven Eschrich, Eric Welsh, Jacques Colinge, John Koomen, Giulio Superti-Furga, Jiannong Li, Uwe Rix, Guolin Zhang, Jae-Young Kim, Keiryn Bennett, Lanxi Song, Ann Chen, Yun Bai
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3_Supplement): IA2.
https://doi.org/10.1158/1078-0432.12AACRIASLC-IA2
Published: 01 February 2012
View article titled, Abstract IA2: Network models in oncogene-addicted lung cancer
Open the PDF for Abstract IA2: Network models in oncogene-addicted lung cancer in another window
Journal Articles

Rapid Immune Recovery and Graft-versus-Host Disease–like Engraftment Syndrome following Adoptive Transfer of Costimulated Autologous T Cells

Aaron P. Rapoport, Edward A. Stadtmauer, Nicole Aqui, Dan Vogl, Anne Chew, Hong-Bin Fang, Stephen Janofsky, Kelly Yager, Elizabeth Veloso, Zhaohui Zheng, Todd Milliron, Sandra Westphal, Julio Cotte, Hong Huynh, Andrea Cannon, Saul Yanovich, Gorgun Akpek, Ming Tan, Kristen Virts, Kathleen Ruehle, Carolynn Harris, Sunita Philip, Robert H. Vonderheide, Bruce L. Levine, Carl H. June
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (13): 4499–4507.
https://doi.org/10.1158/1078-0432.CCR-09-0418
Published: 01 July 2009
View article titled, Rapid Immune Recovery and Graft-versus-Host Disease–like Engraftment Syndrome following Adoptive Transfer of Costimulated Autologous T Cells
Open the PDF for Rapid Immune Recovery and Graft-versus-Host Disease–like Engraftment Syndrome following Adoptive Transfer of Costimulated Autologous T Cells in another window
Includes: Supplementary data
Journal Articles

Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias

Ken Shiozawa, Takeo Nakanishi, Ming Tan, Hong-Bin Fang, Wen-chyi Wang, Martin J. Edelman, David Carlton, Ivana Gojo, Edward A. Sausville, Douglas D. Ross
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (5): 1698–1707.
https://doi.org/10.1158/1078-0432.CCR-08-1587
Published: 27 February 2009
View article titled, Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias
Open the PDF for Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias in another window
Includes: Supplementary data
Journal Articles

Genetic Deletions in Sputum as Diagnostic Markers for Early Detection of Stage I Non–Small Cell Lung Cancer

Ruiyun Li, Nevins W. Todd, Qi Qiu, Tao Fan, Richard Y. Zhao, William H. Rodgers, Hong-Bin Fang, Ruth L. Katz, Sanford A. Stass, Feng Jiang
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (2): 482–487.
https://doi.org/10.1158/1078-0432.CCR-06-1593
Published: 25 January 2007
View article titled, Genetic Deletions in Sputum as Diagnostic Markers for Early Detection of Stage I Non–Small Cell Lung Cancer
Open the PDF for Genetic Deletions in Sputum as Diagnostic Markers for Early Detection of Stage I Non–Small Cell Lung Cancer in another window